Understanding the genetics of neuropsychiatric disorders: the potential role of genomic regulatory blocks

被引:0
|
作者
Anja Barešić
Alexander Jolyon Nash
Tarik Dahoun
Oliver Howes
Boris Lenhard
机构
[1] MRC London Institute of Medical Sciences,Institute of Clinical Sciences, Faculty of Medicine
[2] Imperial College London,Department of Psychiatry
[3] University of Oxford,Sars International Centre for Marine Molecular Biology
[4] Warneford Hospital,undefined
[5] University of Bergen,undefined
来源
Molecular Psychiatry | 2020年 / 25卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Recent genome-wide association studies have identified numerous loci associated with neuropsychiatric disorders. The majority of these are in non-coding regions, and are commonly assigned to the nearest gene along the genome. However, this approach neglects the three-dimensional organisation of the genome, and the fact that the genome contains arrays of extremely conserved non-coding elements termed genomic regulatory blocks (GRBs), which can be utilized to detect genes under long-range developmental regulation. Here we review a GRB-based approach to assign loci in non-coding regions to potential target genes, and apply it to reanalyse the results of one of the largest schizophrenia GWAS (SWG PGC, 2014). We further apply this approach to GWAS data from two related neuropsychiatric disorders—autism spectrum disorder and bipolar disorder—to show that it is applicable to developmental disorders in general. We find that disease-associated SNPs are overrepresented in GRBs and that the GRB model is a powerful tool for linking these SNPs to their correct target genes under long-range regulation. Our analysis identifies novel genes not previously implicated in schizophrenia and corroborates a number of predicted targets from the original study. The results are available as an online resource in which the genomic context and the strength of enhancer–promoter associations can be browsed for each schizophrenia-associated SNP.
引用
收藏
页码:6 / 18
页数:12
相关论文
共 50 条
  • [31] Epigenetic regulation - A key to understanding neuropsychiatric disorders ?
    Frieling, Helge
    Hillemacher, T.
    Kornhuber, J.
    Bleich, S.
    NERVENARZT, 2007, 78 : 285 - 286
  • [32] Understanding Neuropsychiatric Disorders: Insights from Neuroimaging
    Lawrie, Stephen M.
    BRITISH JOURNAL OF PSYCHIATRY, 2011, 199 (02) : 168 - 168
  • [34] Antioxidants as potential therapeutics for neuropsychiatric disorders
    Pandya, Chirayu D.
    Howell, Kristy R.
    Pillai, Anilkumar
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2013, 46 : 214 - 223
  • [35] Neurosteroids: A potential target for neuropsychiatric disorders
    Wang, Mengyu
    Hu, Suwan
    Fu, Xinghuo
    Zhou, Huixuan
    Yang, Siqi
    Yang, Chun
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2024, 239
  • [36] THE ROLE OF SEX IN THE GENETICS AND GENOMICS OF NEUROPSYCHIATRIC TRAITS
    Stranger, Barbara
    Blokland, Gabriella
    Davis, Lea
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : 1031 - 1032
  • [37] Potential pathways emphasizing role of Negr1 in the pathogenesis of neuropsychiatric disorders
    Jayaram, Mohan
    Singh, Katyayani
    Promet, Liisi
    Jagomae, Toomas
    Kasvandik, Sergo
    Kumar, Neeraj
    Lillevali, Kersti
    Philips, Mari-Anne
    Vasar, Eero
    ACTA PHYSIOLOGICA, 2023, 239
  • [38] Unveiling the potential of estrogen: Exploring its role in neuropsychiatric disorders and exercise intervention☆
    He, Wenke
    Zhang, Sen
    Qi, Zhengtang
    Liu, Weina
    PHARMACOLOGICAL RESEARCH, 2024, 204
  • [39] REGULATORY GENOMIC VARIATION IN THE DEVELOPING BRAIN: RELEVANCE TO NEUROPSYCHIATRIC PHENOTYPES
    Mill, Jonathan
    Hannon, Eilis
    Spiers, Helen
    Wong, Chloe Chung Yi
    Viana, Joana
    O'Donovan, Michael
    Schalkwyk, Leo
    Bray, Nick
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S773 - S773
  • [40] The role of basal ganglia in neuropsychiatric disorders
    Castelo-Branco, Miguel
    TOXICOLOGY LETTERS, 2017, 280 : S63 - S63